|
|
|
|
|
Adriana Nowak, Tadeusz Bakula, Katarzyna Matusiak, Remigiusz Galecki, Sebastian Borowski and Beata Gutarowska
-
|
|
|
|
|
|
|
|
|
|
|
Sendren Sheng-Dong Xu, Chun-Chao Chang, Chien-Tien Su and Pham Quoc Phu
This paper discusses using computer-aided diagnosis (CAD) to distinguish between hepatocellular carcinoma (HCC), i.e., the most common type of primary liver malignancy and a leading cause of death in people with cirrhosis worldwide, and liver abscess bas...
ver más
|
|
|
|
|
|
|
|
|
|
|
Cosimo Cardellicchio, Valentino Laquintana, Rosa Maria Iacobazzi, Nunzio Denora, Antonio Scilimati, Maria Grazia Perrone and Maria Annunziata M. Capozzi
Sulindac is a well-known anti-inflammatory agent, sometimes employed as an adjuvant in antitumor therapy. Due to the recent interest in sulfoximine for its potential chemotherapeutics, we decided to transform sulindac and its methyl ester into the corres...
ver más
|
|
|
|
|
|
|
|
|
|
|
Chih-Jan Ko, Chia-Jung Li, Meng-Yu Wu and Pei-Yi Chu
Hepatocarcinogenesis and distant metastasis pose major challenges for physicians. They are regulated by several genes, such as AKT, JUK, Wnt, and P53, and their expression activates several important processes such as cell proliferation, migration, motil...
ver más
|
|
|
|
|
|
|
|
|
|
|
Shiro Miyayama
Transarterial chemoembolization (TACE) is a first-line treatment for patients with hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer stage B (BCLC-B). There are two major techniques of TACE: conventional TACE (cTACE) using iodized oil and g...
ver más
|
|
|
|
|
|